GC15291
GSK3145095
Also known as 5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide
GSK3145095 is a RIP1 kinase inhibitor
ChemicalCAS1622849-43-7MW397.38FormulaC₂₀H₁₇F₂N₅O₂
- CAS number
- 1622849-43-7
- Molecular weight
- 397.38
- Formula
- C₂₀H₁₇F₂N₅O₂
- Solubility
- Soluble in DMSO
- InChIKey
- ATQAGKAMBISZQM-HNNXBMFYSA-N
- Catalogue number
- GC15291
- Brand
- GLPBIO
Computed properties PubChem CID 118557502 · XLogP 3.1 · TPSA 99.8 Ų · H-bond donors 3
- XLogP
- 3.1
- TPSA
- 99.8 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 29
SMILES C1CC2=C(C(=CC(=C2)F)F)NC(=O)[C@H]1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4
Computed descriptors from PubChem (CID 118557502), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il